LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

Putative nitrate reductase

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
Putative nitrate reductase
Gene product:
nitrate reductase - putative
Species:
Leishmania infantum
UniProt:
A4I589_LEIIN
TriTrypDb:
LINF_300011200
Length:
537

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) yes yes: 2
Forrest at al. (procyclic) yes yes: 2
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 10
NetGPI no yes: 0, no: 10
Could not find GO cellular_component term for this entry.

Expansion

Sequence features

A4I589
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: A4I589

Function

Could not find GO biological_process term for this entry.
Molecular functions
Term Name Level Count
GO:0003824 catalytic activity 1 11
GO:0005488 binding 1 10
GO:0008940 nitrate reductase activity 4 8
GO:0009703 nitrate reductase (NADH) activity 6 8
GO:0016491 oxidoreductase activity 2 11
GO:0016661 oxidoreductase activity, acting on other nitrogenous compounds as donors 3 8
GO:0020037 heme binding 4 10
GO:0043167 ion binding 2 10
GO:0043169 cation binding 3 10
GO:0046857 oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor 4 8
GO:0046872 metal ion binding 4 10
GO:0046906 tetrapyrrole binding 3 10
GO:0050463 nitrate reductase [NAD(P)H] activity 5 8
GO:0097159 organic cyclic compound binding 2 10
GO:1901363 heterocyclic compound binding 2 10
GO:0004128 cytochrome-b5 reductase activity, acting on NAD(P)H 5 1
GO:0016651 oxidoreductase activity, acting on NAD(P)H 3 1
GO:0016653 oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor 4 1

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 133 137 PF00656 0.452
CLV_C14_Caspase3-7 514 518 PF00656 0.439
CLV_NRD_NRD_1 127 129 PF00675 0.482
CLV_NRD_NRD_1 147 149 PF00675 0.219
CLV_NRD_NRD_1 260 262 PF00675 0.576
CLV_NRD_NRD_1 443 445 PF00675 0.397
CLV_NRD_NRD_1 81 83 PF00675 0.748
CLV_PCSK_KEX2_1 127 129 PF00082 0.433
CLV_PCSK_KEX2_1 259 261 PF00082 0.639
CLV_PCSK_KEX2_1 443 445 PF00082 0.490
CLV_PCSK_SKI1_1 123 127 PF00082 0.476
CLV_PCSK_SKI1_1 132 136 PF00082 0.437
CLV_PCSK_SKI1_1 196 200 PF00082 0.397
CLV_PCSK_SKI1_1 244 248 PF00082 0.418
CLV_PCSK_SKI1_1 302 306 PF00082 0.458
CLV_PCSK_SKI1_1 461 465 PF00082 0.418
CLV_PCSK_SKI1_1 82 86 PF00082 0.654
DEG_SCF_FBW7_1 50 56 PF00400 0.742
DEG_SPOP_SBC_1 6 10 PF00917 0.616
DOC_CKS1_1 333 338 PF01111 0.501
DOC_CKS1_1 430 435 PF01111 0.491
DOC_CKS1_1 50 55 PF01111 0.741
DOC_MAPK_gen_1 212 221 PF00069 0.515
DOC_MAPK_MEF2A_6 457 466 PF00069 0.499
DOC_PP2B_LxvP_1 72 75 PF13499 0.808
DOC_PP4_FxxP_1 306 309 PF00568 0.439
DOC_PP4_FxxP_1 333 336 PF00568 0.516
DOC_PP4_FxxP_1 371 374 PF00568 0.521
DOC_USP7_MATH_1 160 164 PF00917 0.664
DOC_USP7_UBL2_3 243 247 PF12436 0.396
DOC_WW_Pin1_4 161 166 PF00397 0.722
DOC_WW_Pin1_4 168 173 PF00397 0.797
DOC_WW_Pin1_4 206 211 PF00397 0.480
DOC_WW_Pin1_4 259 264 PF00397 0.642
DOC_WW_Pin1_4 332 337 PF00397 0.367
DOC_WW_Pin1_4 429 434 PF00397 0.491
DOC_WW_Pin1_4 46 51 PF00397 0.845
DOC_WW_Pin1_4 467 472 PF00397 0.495
LIG_14-3-3_CanoR_1 294 304 PF00244 0.425
LIG_14-3-3_CanoR_1 448 455 PF00244 0.516
LIG_14-3-3_CanoR_1 490 496 PF00244 0.537
LIG_14-3-3_CanoR_1 7 13 PF00244 0.792
LIG_14-3-3_CanoR_1 82 88 PF00244 0.615
LIG_BRCT_BRCA1_1 356 360 PF00533 0.433
LIG_BRCT_BRCA1_1 422 426 PF00533 0.316
LIG_FHA_1 111 117 PF00498 0.442
LIG_FHA_1 171 177 PF00498 0.792
LIG_FHA_1 185 191 PF00498 0.628
LIG_FHA_1 285 291 PF00498 0.532
LIG_FHA_1 296 302 PF00498 0.405
LIG_FHA_1 402 408 PF00498 0.514
LIG_FHA_1 457 463 PF00498 0.448
LIG_FHA_1 99 105 PF00498 0.526
LIG_FHA_2 430 436 PF00498 0.530
LIG_FHA_2 512 518 PF00498 0.530
LIG_FHA_2 53 59 PF00498 0.819
LIG_FHA_2 84 90 PF00498 0.495
LIG_Integrin_isoDGR_2 226 228 PF01839 0.530
LIG_Integrin_isoDGR_2 353 355 PF01839 0.452
LIG_LIR_Apic_2 305 309 PF02991 0.443
LIG_LIR_Apic_2 330 336 PF02991 0.462
LIG_LIR_Apic_2 368 374 PF02991 0.405
LIG_LIR_Gen_1 232 242 PF02991 0.428
LIG_LIR_Nem_3 232 237 PF02991 0.385
LIG_LIR_Nem_3 300 306 PF02991 0.543
LIG_LIR_Nem_3 331 337 PF02991 0.417
LIG_LIR_Nem_3 357 363 PF02991 0.441
LIG_MLH1_MIPbox_1 356 360 PF16413 0.433
LIG_OCRL_FandH_1 233 245 PF00620 0.413
LIG_Pex14_2 333 337 PF04695 0.530
LIG_REV1ctd_RIR_1 358 368 PF16727 0.433
LIG_SH2_CRK 323 327 PF00017 0.481
LIG_SH2_GRB2like 323 326 PF00017 0.530
LIG_SH2_STAP1 449 453 PF00017 0.530
LIG_SH2_STAT5 250 253 PF00017 0.406
LIG_SH2_STAT5 303 306 PF00017 0.490
LIG_SH2_STAT5 334 337 PF00017 0.405
LIG_SH2_STAT5 359 362 PF00017 0.458
LIG_SH3_1 260 266 PF00018 0.467
LIG_SH3_3 251 257 PF00018 0.512
LIG_SH3_3 260 266 PF00018 0.623
LIG_SH3_3 276 282 PF00018 0.607
LIG_SH3_3 371 377 PF00018 0.385
LIG_SH3_3 427 433 PF00018 0.491
LIG_SH3_3 47 53 PF00018 0.840
LIG_SH3_3 506 512 PF00018 0.510
LIG_SUMO_SIM_anti_2 101 107 PF11976 0.431
LIG_SUMO_SIM_par_1 101 107 PF11976 0.530
LIG_SUMO_SIM_par_1 461 467 PF11976 0.518
LIG_TRAF2_1 14 17 PF00917 0.841
LIG_TRAF2_1 167 170 PF00917 0.832
LIG_TRAF2_1 391 394 PF00917 0.590
LIG_TRAF2_1 65 68 PF00917 0.855
LIG_TRFH_1 249 253 PF08558 0.530
LIG_WRC_WIRS_1 112 117 PF05994 0.458
LIG_WRC_WIRS_1 303 308 PF05994 0.530
MOD_CDC14_SPxK_1 262 265 PF00782 0.627
MOD_CDK_SPxK_1 206 212 PF00069 0.480
MOD_CDK_SPxK_1 259 265 PF00069 0.663
MOD_CDK_SPxK_1 332 338 PF00069 0.484
MOD_CK1_1 140 146 PF00069 0.537
MOD_CK1_1 161 167 PF00069 0.664
MOD_CK1_1 297 303 PF00069 0.543
MOD_CK1_1 411 417 PF00069 0.530
MOD_CK1_1 422 428 PF00069 0.518
MOD_CK1_1 429 435 PF00069 0.447
MOD_CK1_1 447 453 PF00069 0.497
MOD_CK1_1 467 473 PF00069 0.543
MOD_CK1_1 480 486 PF00069 0.316
MOD_CK1_1 8 14 PF00069 0.642
MOD_CK2_1 52 58 PF00069 0.766
MOD_CK2_1 62 68 PF00069 0.839
MOD_CK2_1 83 89 PF00069 0.597
MOD_GlcNHglycan 10 13 PF01048 0.794
MOD_GlcNHglycan 123 126 PF01048 0.509
MOD_GlcNHglycan 142 145 PF01048 0.253
MOD_GlcNHglycan 273 276 PF01048 0.673
MOD_GlcNHglycan 356 359 PF01048 0.492
MOD_GlcNHglycan 64 67 PF01048 0.783
MOD_GSK3_1 111 118 PF00069 0.419
MOD_GSK3_1 184 191 PF00069 0.618
MOD_GSK3_1 22 29 PF00069 0.817
MOD_GSK3_1 328 335 PF00069 0.492
MOD_GSK3_1 336 343 PF00069 0.415
MOD_GSK3_1 416 423 PF00069 0.408
MOD_GSK3_1 44 51 PF00069 0.807
MOD_GSK3_1 444 451 PF00069 0.242
MOD_GSK3_1 472 479 PF00069 0.476
MOD_GSK3_1 492 499 PF00069 0.402
MOD_LATS_1 319 325 PF00433 0.484
MOD_LATS_1 5 11 PF00433 0.717
MOD_N-GLC_1 295 300 PF02516 0.548
MOD_NEK2_1 115 120 PF00069 0.406
MOD_NEK2_1 304 309 PF00069 0.475
MOD_NEK2_1 33 38 PF00069 0.775
MOD_NEK2_1 426 431 PF00069 0.385
MOD_NEK2_1 44 49 PF00069 0.817
MOD_NEK2_1 464 469 PF00069 0.456
MOD_NEK2_2 137 142 PF00069 0.530
MOD_PIKK_1 281 287 PF00454 0.537
MOD_PIKK_1 416 422 PF00454 0.530
MOD_PIKK_1 529 535 PF00454 0.555
MOD_PKA_2 354 360 PF00069 0.490
MOD_PKA_2 447 453 PF00069 0.473
MOD_PKA_2 489 495 PF00069 0.530
MOD_PKA_2 6 12 PF00069 0.801
MOD_Plk_1 110 116 PF00069 0.387
MOD_Plk_1 328 334 PF00069 0.355
MOD_Plk_1 472 478 PF00069 0.530
MOD_Plk_4 111 117 PF00069 0.521
MOD_Plk_4 217 223 PF00069 0.532
MOD_Plk_4 230 236 PF00069 0.260
MOD_Plk_4 422 428 PF00069 0.413
MOD_ProDKin_1 161 167 PF00069 0.724
MOD_ProDKin_1 168 174 PF00069 0.794
MOD_ProDKin_1 206 212 PF00069 0.480
MOD_ProDKin_1 259 265 PF00069 0.635
MOD_ProDKin_1 332 338 PF00069 0.367
MOD_ProDKin_1 429 435 PF00069 0.491
MOD_ProDKin_1 46 52 PF00069 0.848
MOD_ProDKin_1 467 473 PF00069 0.495
TRG_DiLeu_BaEn_1 89 94 PF01217 0.530
TRG_DiLeu_BaEn_4 67 73 PF01217 0.714
TRG_ENDOCYTIC_2 303 306 PF00928 0.537
TRG_ENDOCYTIC_2 323 326 PF00928 0.199
TRG_ENDOCYTIC_2 334 337 PF00928 0.405
TRG_ER_diArg_1 126 128 PF00400 0.433
TRG_ER_diArg_1 179 182 PF00400 0.555
TRG_ER_diArg_1 259 261 PF00400 0.668
TRG_ER_diArg_1 442 444 PF00400 0.490
TRG_Pf-PMV_PEXEL_1 148 152 PF00026 0.474
TRG_Pf-PMV_PEXEL_1 188 192 PF00026 0.558
TRG_Pf-PMV_PEXEL_1 288 293 PF00026 0.539

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1HZN6 Leptomonas seymouri 44% 85%
A0A1X0P389 Trypanosomatidae 34% 100%
A0A3Q8IJ69 Leishmania donovani 99% 100%
A0A422NIH2 Trypanosoma rangeli 33% 100%
A4HI12 Leishmania braziliensis 71% 100%
C9ZQM0 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 29% 100%
E9B0I6 Leishmania mexicana (strain MHOM/GT/2001/U1103) 85% 100%
Q4Q7P5 Leishmania major 89% 100%
V5B7R2 Trypanosoma cruzi 35% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS